ARIAD Pharmaceuticals, Inc. — Revenue by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/1ee9b9bb-bb16-4b31-a7ef-fa842340655b/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2015 | $112.5M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-485544 |
| FY 2014 | $55.7M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-073392 |
| FY 2013 | $45.2M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-080539 |
| FY 2012 | $558.0k | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-087814 |
| FY 2011 | $25.3M | 2011-01-01 – 2011-12-31 | evidence 0001157523-12-001143 |
| FY 2010 | $179.0M | 2010-01-01 – 2010-12-31 | evidence 0001157523-12-001143 |
| FY 2009 | $8.3M | 2009-01-01 – 2009-12-31 | evidence 0001157523-12-001143 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ARIAD Pharmaceuticals, Inc. — all facts · Net Income · Operating Income